| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080177042 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 07/24/2008 | US20080177037 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080176933 administering to an immunosuppressed patient or a patient diagnosed with sepsis or septic shock; administering to a patient diagnosed with a gram negative bacterial infection; degree of polymerization of all the proanthocyanidins in the composition is at least about 6 |
| 07/24/2008 | US20080176926 Hydrogenated Benzo (C) Thiophene Derivatives as Immunomodulators |
| 07/24/2008 | US20080176924 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
| 07/24/2008 | US20080176896 Modulators of cellular adhesion |
| 07/24/2008 | US20080176888 Sirolimus Formulation |
| 07/24/2008 | US20080176867 e.g., N-[[5-(4-bromophenyl)-4-(2,4-dichlorophenyl)pyrimidin-2-yl]methyl]-3-(trifluoromethyl)benzenesulfonamide; cannabinoid receptor modulator; metabolic and gastrointenstinal disorders, antidiabetic, antiinflammatory, analgesic agent; neurodegenerative diseases |
| 07/24/2008 | US20080176851 by blocking sGC.alpha.1.beta.1 signaling; applying sGC inhibitor such as NS-2028 (4H-8-Bromo-1,2,4-oxadiazolo(3,4-d)benz(b)(1,4)oxazin-1-one) on skin; inhibitor of Soluble Guanylate Cyclase (sGC), a receptor for NO; preventing Nitric oxide-induced lymphatic endothelial cell proliferation |
| 07/24/2008 | US20080176846 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent |
| 07/24/2008 | US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders |
| 07/24/2008 | US20080176840 e.g. 4-(4-(6-(N-(2-methoxyethyl)-N-methylamino)pyridin-3-yl)-5-hydroxy-4H-1,2,4-triazol-3-yl)-6-isopropylbenzene-1,3-diol; Heat Shock Protein 90 (HSP90) modulator; antiproliferative, anticarcinogenic, antiinflammatory agent; angiogenesis inhibition, infections |
| 07/24/2008 | US20080176830 Compounds, Compositions, and Methods |
| 07/24/2008 | US20080176824 Pharmaceutical Compositions 3 |
| 07/24/2008 | US20080176820 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 07/24/2008 | US20080176813 Carbocyclic nucleosides and process for obtaining such |
| 07/24/2008 | US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones |
| 07/24/2008 | US20080176794 Long lasting fusion peptide inhibitors of viral infection |
| 07/24/2008 | US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 07/24/2008 | US20080175971 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 07/24/2008 | US20080175923 Methods and Compositions Related to Regulation of Cytokine Production by Glycogen Synthase Kinase 3 (Gsk-3) |
| 07/24/2008 | US20080175914 Inflammatory and/or allergic diseases; cognitive impairment |
| 07/24/2008 | US20080175888 regulate an immune response in a mammal contains kiwi fruit plant extract; veterinary medicine; antiinflammatory agent for treating allergic and non-allergic inflammatory conditions, skin disorders; side effect reduction |
| 07/24/2008 | US20080175884 Polymer coatings as carriers for the drug delivery of a methosyaminocarbonyloxy derivative of rapamycin and another drug(s) such as an antiproliferative agent, anticoagulant, etc.; reduces restenosis in vasculature procedures to a level of 0-25%; coronary/periferal stents; grafts ; balloons |
| 07/24/2008 | US20080175871 Eliciting improved immune responses |
| 07/24/2008 | US20080175870 Human Cancer Stem Cells |
| 07/24/2008 | US20080175857 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 07/24/2008 | US20080175856 Enterococcus Antigens |
| 07/24/2008 | US20080175850 Methods for human allografting |
| 07/24/2008 | US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies |
| 07/24/2008 | US20080175830 Culture-expanded T suppressor cells and methods of use thereof |
| 07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | US20080175795 e.g. 3-{4-[4-(2-amino-2-carbamoyl-ethyl)-phenoxy]-phenyl)-propionic acid; antiinflammatory and immunological diseases, cytokines (TNF- alpha , IL-1, IL-6), orexin, nitric oxide synthase inhibitor; obesity, hyperlipidemia, migraine, asthma, chronic obstructive pulmonary disease, osteoarthritis |
| 07/24/2008 | US20080175794 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues |
| 07/24/2008 | CA2712056A1 Method of inducing an immune response |
| 07/24/2008 | CA2675733A1 Method for glycosylation of flavonoid compounds |
| 07/24/2008 | CA2675520A1 New combination for use in the treatment of inflammatory disorders |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/24/2008 | CA2667678A1 Toxin peptide therapeutic agents |
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947183A1 Mammalian cell surface antigens; related reagents |
| 07/23/2008 | EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 07/23/2008 | EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2008 | EP1947110A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase |
| 07/23/2008 | EP1946776A1 Stabilized TNFR-Fc composition comprising arginine |
| 07/23/2008 | EP1946773A2 Improved saponin adjuvant compositions and methods relating thereto |
| 07/23/2008 | EP1946769A2 Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B |
| 07/23/2008 | EP1946767A2 Autologous T-cell vaccines against multiple sclerosis |
| 07/23/2008 | EP1946756A1 Use of entacapone in cosmetic, dermatological and pharmaceutical compositions |
| 07/23/2008 | EP1946753A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 07/23/2008 | EP1946752A1 Anti-allergic agent |
| 07/23/2008 | EP1945672A2 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 07/23/2008 | EP1945665A2 Antibody-based therapeutics with enhanced adcc activity |
| 07/23/2008 | EP1945305A2 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases |
| 07/23/2008 | EP1945264A2 Treatment for antiphospholipid-syndrome-related pregnancy complications |
| 07/23/2008 | EP1945246A2 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 07/23/2008 | EP1740144A4 Phototherapy systems and methods |
| 07/23/2008 | EP1527781B1 Antipruritic agent |
| 07/23/2008 | EP1523988B1 Composition comprising radix codonopsis pilosulae and radix astragali for the treatment of acute lung injury |
| 07/23/2008 | EP1471901B1 Spermidine derivative for the treatment of chronic neurodegenerative diseases |
| 07/23/2008 | EP1469733A4 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1342723B1 Indole derivatives and use thereof in medicines |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1270595B1 Anti ccr4 antibody and its fragment |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1163271B1 Recombinant il-18 antibodies and their use |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | CN101228188A IL-1β结合抗体及其片段 IL-1β binding antibodies and fragments |
| 07/23/2008 | CN101228146A Benzofuran derivatives with therapeutic activities |
| 07/23/2008 | CN101227923A Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue |
| 07/23/2008 | CN101227901A Anti-inflammatory agents |
| 07/23/2008 | CN101225391A Recombinant human interferon regulatory factor 4 binding protein expression system as well as preparation method and uses thereof |
| 07/23/2008 | CN101225390A MS gene order of diffuse large B cell lymphoma related antigen specific TCR V alpha 6 subfamily and uses thereof |
| 07/23/2008 | CN101225389A VR gene order of diffuse large B cell lymphoma related antigen specific TCR V alpha 23 subfamily and uses thereof |
| 07/23/2008 | CN101225388A MR gene order of diffuse large B cell lymphoma related antigen specific TCR V alpha 6 subfamily and uses thereof |
| 07/23/2008 | CN101225107A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/23/2008 | CN101224300A Application of colon bacillus OmpA as animal immunity regulator |
| 07/23/2008 | CN101224284A Compounds for treating Hepatitis B and preparing method thereof |
| 07/23/2008 | CN101224257A Polypeptide soft capsule without free radical and preparing method thereof |
| 07/23/2008 | CN101224231A Method of extracting immunologic adjuvant component from cochinchina momordica seed |
| 07/23/2008 | CN101224220A Compounds for strengthening organism immunity function and application thereof |
| 07/23/2008 | CN101224215A Uses of ursolic acid saponin and oleanolic acid saponin in preparing medicine for increasing white blood cell and/or blood platelet |
| 07/23/2008 | CN101224210A Mizolastine sustained release capsule |
| 07/23/2008 | CN101224200A Novel anti-systematic erythema lupus medicine |
| 07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/23/2008 | CN100404684C Process for preparing high-purity amino acid and immune bioactive peptide |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404070C Packaged virus-like particles |
| 07/23/2008 | CN100404038C A health product of lucid ganoderma and preparation method thereof |
| 07/22/2008 | US7402688 novel 2,2-disubstituted-19-norvitamin D derivatives and 20-epi-19-norvitamin D derivatives; metabolic regulatory hormone of calcium and phosphorus; biological activities: cellular induced differentiation, suppression of proliferation, and immunomodulation by transcription control of target gene |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402662 Antibody molecules specific to human tumor necrosis factor alpha |